Good morning :)
Switch to
Place Order

Krebs Biochemicals and Industries Ltd

KREBSBIO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹391 cr, stock is ranked 1,281
High RiskStock is 4.71x as volatile as Nifty
179.452.35 (-1.29%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹391 cr, stock is ranked 1,281
High RiskStock is 4.71x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-13.83
PB RatioPB Ratio
-30.79
Dividend YieldDiv. Yield
Sector PESector PE
39.59
Sector PBSector PB
5.30
Sector Div YldSctr Div Yld
0.65%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Krebs Biochemicals and Industries Limited is engaged in the business of manufacture of active pharmaceutical ingredients. The Company is producing a number of pain killers, anti-asthmatic and anti-human immunodeficiency virus (HIV) drugs.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

201820192020202134.1348.2033.7854.32-17.83-20.01-28.87-28.35
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 2.71%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Trading Window 
Announced OnSep 27, 2021

Krebs Biochemicals and Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Krebs Biochemicals and Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Shareholders meeting 
Announced OnSep 24, 2021

The Company is re-submitting its scrutinizer report for 29th Annual General meeting held on 23rd September, 2021 as the previously submitted report had one typing error. | Download

The Company is re-submitting its scrutinizer report for 29th Annual General meeting held on 23rd September, 2021 as the previously submitted report had one typing error. | Download

Shareholders meeting 
Announced OnSep 23, 2021

Krebs Biochemicals and Industries Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 23, 2021 | Download

Krebs Biochemicals and Industries Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 23, 2021 | Download

See all events